// App-Quantinova.ai

215 : Rivaroxaban Versus Low Molecular Weight Heparin For The Prevention Of Venous Thromboembolism After Orthopedic Surgery: A Population-Based Study

Researchers

Presenter

  • Alejandro Lazo-Langner

Principal Investigators

  • Jamie L. Fleet

  • Eric McArthur

  • Amit X. Garg

Medical Centers

  • Department of Medicine, Division of Nephrology, University of Western Ontario, London, ON, Canada

  • University of Western Ontario, London Health Sciences Centre, London,Canada

  • Department of Medicine, Division of Hematology, University of Alberta, Edmonton, AB, Canada

  • Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada

  • ICES (Institute for Clinical Evaluative Sciences) Western, London, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Gastrointestinal bleeding

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • Transketolase Like 1

Drug/Treatment

  • rivaroxaban

  • dalteparin Subcutaneous

  • Enoxaparin

  • Enoxaparin sodium

  • Pradax

  • Tinzaparin

  • apixaban

  • Heparin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved